Insider · CIK 0001593087

Bergmann Anthony

Reports to the SEC for 1 company · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001593087

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-25	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+24.1K sh	$3.18	+$76.6K	35,323
2026-06-25	CAPRCAPRICOR THERAPEUTICS, INC.S Sale	CHIEF FINANCIAL OFFICER	SSale	−24.1K sh	$30.38	−$732K	11,223
2026-06-25	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−24.1K sh	—	—	91,980
2026-06-24	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+400 sh	$3.18	+$1,272	11,623
2026-06-24	CAPRCAPRICOR THERAPEUTICS, INC.S Sale	CHIEF FINANCIAL OFFICER	SSale	−400 sh	$30.00	−$12K	11,223
2026-06-24	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−400 sh	—	—	116,080
2026-06-22	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+500 sh	$3.18	+$1,590	11,723
2026-06-22	CAPRCAPRICOR THERAPEUTICS, INC.S Sale	CHIEF FINANCIAL OFFICER	SSale	−500 sh	$30.00	−$15K	11,223
2026-06-22	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−500 sh	—	—	116,480
2026-05-18	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+3,000 sh	$1.39	+$4,170	11,223
2026-05-18	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−3,000 sh	—	—	0
2026-05-01	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+25K sh	$3.18	+$79.5K	33,223
2026-05-01	CAPRCAPRICOR THERAPEUTICS, INC.S Sale	CHIEF FINANCIAL OFFICER	SSale	−25K sh	$31.70	−$793K	8,223
2026-05-01	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−25K sh	—	—	116,980
2026-03-31	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+25K sh	$3.18	+$79.5K	33,223
2026-03-31	CAPRCAPRICOR THERAPEUTICS, INC.S Sale	CHIEF FINANCIAL OFFICER	SSale	−25K sh	$30.13	−$753K	8,223
2026-03-31	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−25K sh	—	—	141,980
2026-01-05	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+25K sh	—	—	25,000
2026-01-05	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+25K sh	—	—	25,000
2026-01-05	CAPRCAPRICOR THERAPEUTICS, INC. · Restricted Stock UnitsA Award	CHIEF FINANCIAL OFFICER	AAward	+2,500 sh	—	—	2,500
2025-03-03	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,500 sh	$1.39	+$3,475	8,223
2025-03-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−2,500 sh	—	—	0
2025-01-02	CAPRCAPRICOR THERAPEUTICS, INC.A Award	CHIEF FINANCIAL OFFICER	AAward	+3,342 sh	—	—	5,723
2025-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+75K sh	—	—	75,000
2025-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+6,170 sh	—	—	6,170
2024-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+85K sh	—	—	85,000
2024-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+9,692 sh	—	—	9,692
2023-10-23	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+2,178 sh	$1.39	+$3,027.42	2,381
2023-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+85K sh	—	—	85,000
2022-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+167K sh	—	—	166,980
2021-01-04	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+95.7K sh	—	—	95,693
2020-06-05	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+120K sh	—	—	120,003
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+14K sh	—	—	14,000
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+5,000 sh	—	—	5,000
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+3,500 sh	—	—	3,500
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+3,000 sh	—	—	3,000
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+2,500 sh	—	—	2,500
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+2,178 sh	—	—	2,178
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−14K sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−5,000 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−3,500 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−3,000 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−2,500 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	CHIEF FINANCIAL OFFICER	DDisposition to Issuer	−2,178 sh	—	—	0
2019-08-08	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+14K sh	—	—	14,000
2018-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+50K sh	—	—	50,000
2017-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+35K sh	—	—	35,000
2016-06-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+30K sh	—	—	30,000
2016-03-16	CAPRCAPRICOR THERAPEUTICS, INC.P Purchase	CHIEF FINANCIAL OFFICER	PPurchase	+2,030 sh	$2.40	+$4,872	2,030
2016-03-16	CAPRCAPRICOR THERAPEUTICS, INC. · Warrants (Right to Buy)P Purchase	CHIEF FINANCIAL OFFICER	PPurchase	+1,015 sh	$0.13	+$126.875	1,015

Recent filings

Accepted (ET)
Jun 294
Bergmann Anthony0001593087-26-000013
SEC(opens sec.gov)
Jun 244
Bergmann Anthony0001593087-26-000011
SEC(opens sec.gov)
May 194
Bergmann Anthony0001593087-26-000009
SEC(opens sec.gov)
May 44
Bergmann Anthony0001593087-26-000007
SEC(opens sec.gov)
Apr 14
Bergmann Anthony0001593087-26-000005
SEC(opens sec.gov)
Jan 74
Bergmann Anthony0001593087-26-000002
SEC(opens sec.gov)

Companies

CAPRICOR THERAPEUTICS, INC.CHIEF FINANCIAL OFFICERCAPR

Address

C/O CAPRICOR THERAPEUTICS, INC. 10865 ROAD TO THE CURE, SUITE 150

SAN DIEGO, CA, 92121